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Abstract  
Carbon nanotubes (CNTs), the product of new technology, may be used in a wide 
range of applications. Because they present similarities to asbestos fibres in terms of 
their shape and size, it is legitimate to raise the question of their safety for human 
health. Recent animal and cellular studies suggest that CNTs elicit tissue and cell 
responses similar to those observed with asbestos fibres, which increases concern 
about the adverse biological effects of CNTs. While asbestos fibres’ mechanisms of 
action are not fully understood, sufficient results are available to develop hypotheses 
about the significant factors underlying their damaging effects. This review will 
summarize the current state of knowledge about the biological effects of CNTs and 
will discuss to what extent they present similarities to those of asbestos fibres. Finally, 
the characteristics of asbestos known to be associated with toxicity will be analyzed to 
address the possible impact of CNTs.  
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1. Introduction 
Carbon nanotubes (CNTs) have unique chemical and physical characteristics as a 
result of their nanostructure. CNTs may be used in a wide range of applications, in 
fields as diverse as electronics and medicine [1,2]. Due to their widespread use, it is 
important to determine the safety of CNTs for the protection of ecological systems 
and human health. Research to investigate the biological effects of CNTs is advancing 
today in order to foresee and prevent their potentially harmful effects. CNTs have 
fibre-like characteristics in terms of their elongated shape, dimensions and aspect 
ratio. As particles with at least one dimension of less than 100 nm, they correspond to 
High Aspect Ratio Nanoparticles (HARN) [3]. In light of the health impact of mineral 
fibres, especially the fibrogenic and carcinogenic potency of asbestos fibres, and the 
health and socio-economical tragedies caused by unregulated asbestos utilization, the 
increasing development and uses of CNTs have triggered concern about their potential 
toxicity [4-8]. 
In recent years, several publications have reported the effects of CNTs. Most studies 
have concerned animal and cell responses, focusing primarily on respiratory diseases, 
especially the inflammatory effects in the lung. However, while inhalation is one 
important probable route of contamination, it must be kept in mind that there are other 
relevant routes of exposure. A severe primary cancer, malignant mesothelioma (MM), 
has been closely linked to asbestos exposure [9,10]. Epidemiological and animal 
studies have shown that asbestos fibres are not the only fibres to be associated with a 
risk of MM development. Epidemiological studies have demonstrated a higher 
incidence of MM in populations exposed to asbestiform and non-asbestos fibres [11-
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14]. Some manmade vitreous fibres have caused MM in animal experiments [15]. The 
question of whether CNTs might potentially be linked to MM development justifies 
further research in this area. Moreover, on the basis of the literature, CNTs have 
already shown effects in animals and in cell systems that are similar to those observed 
with asbestos fibres [1,2,5,7]. Two recent studies showed the occurrence of MM in 
genetically-modified cancer-sensitized mice and in conventional Fischer 344 rats 
exposed to CNTs by intraperitoneal or intrascrotal administration respectively [16,17]. 
These initial results underline the urgent need for information to further our 
knowledge about CNTs’ potential to cause MM. 
MM is a primary tumour of the serosas caused by the neoplastic transformation of 
mesothelial cells. In populations exposed to asbestos fibres, MM mainly occurs in the 
pleura, and to a lesser extent in the peritoneum and pericardium. MM is considered to 
be highly specific to asbestos exposure, and is found in from 60% to over 80% of 
cases [18-23]. In France, the calculated risk of MM attributable to occupational 
asbestos exposure was estimated at 83.2% (95% CI 76.8 to 89.6) in men, and 38.4% 
(95% CI 26.8 to 50.0) in women [24]. Many studies carried out to investigate pleural 
and mesothelial cell response to asbestos fibres have made it possible to reach sound 
hypotheses about the mechanism of action of asbestos fibres in neoplastic mesothelial 
cell transformation. 
The aim of the present review is to explore whether our knowledge of the mechanism 
of action of asbestos fibres could offer a useful paradigm to provide a warning or 
predict the risk of CNTs, to interpret data on animal and cellular responses, and to 
evaluate their potential health effects. For the purposes of our discussion, we consider 
three points: (i) the fate of asbestos fibres following exposure; (ii) their effects on 
mesothelial cells and the biological mechanism associated with the cell response; (iii) 
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the nature of the fibre parameters involved in the harmful effects, and their similarities 
with CNT characteristics. We begin with a summary of current knowledge on the 
toxicology of CNTs, then look at asbestos fibres’ mechanisms of action, focusing on 
carcinogenic effects at the pleural level. Finally, we address the similarities between 
asbestos and CNTs. 
 
2. Toxicology of CNTs 
 
2.1. Context of toxicological studies on CNT 
 
Various kinds of CNTS have been the focus of toxicological studies. CNTs are 
heterogeneous in terms of their structure, impurities and physico-chemical properties. 
Both single-walled (SWCNTs) and multi-walled (MWCNTs) CNTs have been 
examined in toxicological studies, including commercial and laboratory–made CNTs, 
whether purified or used as produced. The effects of CNTs have been investigated 
following in vivo exposure of rodents, and on several types of cells in culture. Most 
studies concerned pulmonary toxicity [1,2,5]. Animal experiments mainly focused on 
inflammatory responses after exposure by intratracheal instillation or aspiration, or 
intraperitoneal injection. In vitro cell systems with several types of mammalian cells 
have been used to study inflammatory responses and genotoxicity. A few in vivo and 
in vitro studies were related to dermal toxicity, and some in vitro studies focused on 
neurons [2]. Toxicity test systems on procaryotes were also used to assess 
genotoxicity. Here our focus will be on respiratory effects.  
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2.2 Biological effects of CNTs  
 
2.2.1. Translocation 
 
Biodistribution of CNTs after deposition in the lung or via other routes has been 
poorly investigated. A translocation of SWCNTs in various organs has been reported 
by several authors [25-29]. In a recent study, MWCNTs deposited by intratracheal 
instillation in rats revealed clearance due to macrophage uptake and the lymphatic 
system without evidence of crossing the pulmonary barrier, six months after 
instillation [29]. It can be noted that macrophage and lymphatic clearance was also 
demonstrated following administration or exposure to asbestos fibres [30-33]. Erdely 
et al. [30] suggest that the release of soluble inflammatory factors could circulate to 
the vascular blood compartment after lung deposition of CNTs. The release of 
circulating factors must be taken into consideration to account for fibre effects. While 
asbestos fibres have been detected in the pleura, soluble molecules could also account 
for the pleural response [34], and genotoxicity may be due to clastogenic factors 
[35,36]. Additional studies are needed to determine the pharmacokinetics of CNTs. 
Regarding the numerous varieties of CNTs associated with a broad scale of physical 
and physico-chemical properties, fundamental studies will be necessary to establish 
the parameters leading the translocation process.  
2.2.2. Biological effects on mesothelial cells 
In vivo effects on mesothelial cells 
Six recently-published studies concerned CNTs’ effects on mesothelial cells. Three 
reported findings from animal experiments and three from cell system studies. One 
animal experiment concerned the mesothelial cell inflammatory response and 
pathological changes after intra-peritoneal injection [37]. The authors exposed 
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C57Bl/6 mice to four samples of MWCNTs of different sizes and aggregation states. 
There was one sample of “short” MWCNTs (from NanoLab, Inc; mean diameter: 
14.8 ± 0.5 nm; mean length: 1-5 µm); two samples of “long” MWCNTs (Long1, from 
Mitsui & Co.; mean diameter: 84.9 ± 1.9 nm; mean length: 40-50 µm [24% > 15 µm 
of length]; Long2 from Univ. Manchester; mean diameter: 165 ± 4.7 nm; mean 
length: 20-100 µm [84% > 15 µm of length]); and one sample of more tangled 
MWCNTs (from NanoLab, Inc.; mean diameter: 10.4 ± 0.3 nm; mean length: 5-
20 µm), as well as carbon black. At the same time, two samples of amosite fibres 
were tested; these were short fibres (4.5% > 15 µm of length) and long fibres (50.4% 
> 15 µm of length) known to be differently pathogenic in rodents. In prior 
experiments, inhalation and intraperitoneal exposure in rats to long amosite fibres 
revealed greater pathogenicity than short fibres in terms of fibrosis and cancer 
[38,39]. In the study reported by Poland et al. [37], inflammation was assessed after 
injection of 50 µg of MWCNTs/mouse, after 24h and seven days. The end points were 
quantification of inflammation in peritoneal lavage and histology of diaphragm. Only 
long samples of MWCNTs and of amosite produced inflammation and granulomas. 
Histological analyses revealed the occurrence of “frustrated phagocytosis” by 
macrophages. These results thus demonstrated some similarities between the 
responses to the long forms of amosite and MWCNTs. Several of the effects of 
asbestos were also found with CNTs. There were higher inflammatory responses with 
samples of long fibres. Only the samples that contained long fibres caused granulomas 
and “frustrated phagocytosis.” 
A long-term study was performed by Takagi et al. [17] who inoculated MWCNTs 
(MWCNTs-7 from Mitsui; diameter: 100 nm; length: 27% > 5µm) in the peritoneal 
cavity of C57Bl/6 p53
+/-
 mice. Because these mice have a mutation in one allele of the 
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Trp53 gene, they are prone to develop cancer. Crocidolite fibres were inoculated as 
positive control. Mesotheliomas were found after exposure to both MWCNTs and 
crocidolite. This study has been discussed on several points, including concern about 
the type of mice, inappropriate exposure methods, high exposure dose, 
underestimation of the number of particles of MWCNTs and poorly-illustrated 
histology [40,41]. Details can be found in the different papers but some of the 
authors’ replies can be summarized here. It is recognized that Trp53
+/-
 mice are more 
prone to develop cancers, and that the response using high doses by the intraperitoneal 
route of exposure provides different information regarding hazard potency. However, 
spontaneous excess of mesotheliomas has not been reported in this type of mice, and 
the injection method is applicable to the hazard approach for mesothelial cells in the 
absence of human data. Concerning the dose, the authors mentioned that other 
experiments using lower doses are in progress, giving similar responses [40]. More 
recently, MWCNTs-7 were administered by a single intrascrotal injection in 7 Fischer 
344 rats (240 µg/rat) maintained for an observation period of 52 weeks [16]. 
Dimensions were 82% of the MWCNTs with a diameter between 70-110 nm, and 
72.5% between 1-4 µm in length. Five vehicle-treated controls and 7 UICC 
crocidolite-treated rats (470 µg/rat) were also studied. The overall incidence of 
mesotheliomas was 86% in MWCNT-treated rats while no mesothelioma was found 
in vehicle- or crocidolite-treated rats. This method of exposure of mesothelial cells is 
not usually used to assess a carcinogenic potency of fibres. However, injury at the 
scrotal mesothelium is used as a method to investigate the repair mechanism of 
peritoneal mesothelium [42,43]. Further data are clearly needed to improve our 
knowledge of the effects of these MWCNTs on mesothelial cells in vivo. 
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Effects on mesothelial cells in vitro 
To the best of our knowledge, four studies have reported in vitro effects on 
mesothelial cells. DNA breakage and DNA repair were found in both human normal 
and malignant mesothelial cells exposed to SWCNTs, as well as cell activation via 
AP-1, NF-κB and Akt [44]. Another study concluded that there was alteration of cell 
viability and decreased cell proliferation in human mesothelioma cells exposed to 
SWCNTs [45]. Three studies reported cytotoxicity on human normal mesothelial 
cells, malignant mesothelioma cell line, and on large T SV40-transformed mesothelial 
cells (Met-5A) [44,46,47]. It is noteworthy that the same raw CNT material with 
different degrees of dispersion exerted different cytotoxicity on a human 
mesothelioma cell line [47]. In this study, the toxicity of CNT-bundles (well-dispersed 
material with a bundle diameter of around 20 nm) was less than that of CNT-
agglomerates (densely roped aggregates with a rope diameter in the micron-range). 
CNTs appear to be taken up by different cell types and diverse in vitro effects have 
been associated with CNTs uptake [2,45]. However, the cellular uptake of CNTs is 
controversial. Both absence and significant uptake have been reported, as recently 
discussed [1]. Uptake is likely dependent on interactions between cellular receptors 
and cell surface functions, and CNTs surface reactivity. A variety of cell surface 
functions may be found, depending on the cell type. CNTs may also carry diverse 
reactive groups. Different sorts of chemicals and biological molecules are currently 
used to disperse CNTs that may modify the CNTs surface. Hence cell-CNT 
interactions are dependent on a number of intrinsic and extrinsic parameters. It should 
be recalled that modification of the surface of asbestos fibres modulates the cell 
responses [48-52]. In macrophages, the scavenger receptor with collagenous structure 
(MARCO) seems to play an important role in pulmonary damage induced by 
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inorganic particles [53] and may be involved in interaction between MWCNTs and 
plasma membrane of macrophages [54]. In mesothelial cells, integrin receptors were 
reported to interact with asbestos fibres [50,55]. Recently, no particle internalisation 
was evidenced in large T SV40-transformed mesothelial cells (MeT-5A) exposed to 
MWCNTs, despite cytotoxicity [46]. Further studies are necessary to clarify these 
controversial results, as fibre internalisation is an important process accounting for the 
adverse cellular effects of particles, and more data are needed to determine the 
interactions of CNT with mesothelial cells. 
 
 
2.2.3. Biological effects in other systems 
Inflammation 
Several studies have investigated the inflammatory response provoked by CNT 
exposure, conducted on mice or rats exposed via intratracheal instillation or 
inhalation. Several reviews may be consulted for more details [1,2,4-8]. Some recent 
data are summarized in Table 1 [30,56-59].  
Regarding the large applications of CNTs and the known adverse effects of fine 
particulate matter, the potential effects of CNTs have also been investigated on 
systems other than respiratory [1,2]. A recent study suggests that deposition of both 
SWCNTs and MWCNTs produce a systemic response, which may affect the 
cardiovascular system [30]. 
Genotoxicity 
Both in vivo and in vitro effects of CNTs suggest a possible genotoxic effect, related 
to inflammatory responses and production of reactive oxygen species, as persistent 
inflammation is considered to increase the carcinogenic risk [60].  
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In vivo, a mutation of the K-ras oncogene was observed in mice exposed to SWCNTs 
by inhalation, and chromosomal aberrations were detected in type II pneumocytes 
after intratracheal deposition of MWCNTs in mice [58,61]. Several in vitro studies 
have reported a genotoxic potency using different cell types (Table 2) 
[44,46,54,57,61-70]. Activation of DNA repair processes and mutagenesis of the 
adenine phosphoribosyl transferase gene was found in mouse embryonic stem cells 
[69]. Genotoxicity as assessed by the cytokinesis-block micronucleus test, was found 
in rat lung epithelial cells exposed to MWCNTs [57]. Micronuclei formation occurred 
in human epithelial cells (MCF-7) treated with MWCNTs, and a pancentrometric 
probe analysis demonstrated both chromosome breakage and chromosome loss [61]. 
DNA damage was also reported in SWCNT-treated mouse embryo fibroblasts and in 
CNT-treated bronchial epithelial BEAS 2B cells [63,67]. No mutation or DNA 
breakage was found in a FE1-Mutatrade markMouse lung epithelial cell line exposed 
to SWCNTs but purine oxidation was detected with the Comet assay [71]. 
Investigations of the mutagenic potency of MWCNTs using bacterial test systems did 
not reveal mutagenic activity [72,73]. These bacterial assays may not be fully relevant 
to evaluate genotoxicity of particles. Previous results with bacterial cells were 
generally not or only moderately positive with asbestos fibres [74]. 
 
3. Asbestos fibres’ mechanism of action 
 
3.1. The asbestos legacy 
Numerous publications on the mechanism of action of asbestos fibres have 
emphasized several responses associated with the mechanism of toxicity at the serosal 
level. They make it clear that two aspects must be considered: the biological response 
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and the particle status. The first depends on several factors that include the fate of 
asbestos fibres following inhalation, i.e., their ability to reach the pleura. It is well 
know that deposition, clearance and translocation of fibres are dependent on 
biological mechanisms and partners (mucociliary transport, phagocytic cells), but also 
on fibre parameters, especially fibre dimensions. Short fibres are more easily 
internalised by macrophages than long fibres, and long fibres possibly involve 
“frustrated phagocytosis.” The biopersistence of fibres is linked to both their 
dimensions and stability in the biological milieu.  
3.2. Fate of asbestos fibres 
 
Regarding industrial uses and commercial applications of asbestos fibres, the main 
risk of contamination is linked to the inhalation route. In general, particle deposition 
depends on aerodynamic considerations. Several authors have studied the mechanism 
of fibre deposition and retention in the lungs [75-78]. Once deposited in the lung, 
asbestos fibres may be translocated into different organs and tissues, including the 
pleura. This was demonstrated in animals following inhalation or intratracheal 
deposition [79], and in humans by investigation of fibre retention in different body 
compartments including the pleura [80-82]. A recent paper discusses the translocation 
pathways of asbestos fibres to the pleura [83]. Translocation appears to be due to 
trans-cell migration and lymphatic circulation. These authors propose that fibres 
deposited in the alveolar space can be translocated to the interstitium, down the 
gradient of physiological water absorption. This transfer is facilitated when the 
epithelial layer is damaged. Once in the interstitium, fibres can be distributed to 
different organs. Fibres can be cleared from the interstitium via the lymphatic system 
and enter the capillaries as inflammation increases the interstitial pressure, allowing 
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the fibres to migrate and be distributed throughout the whole body. Therefore, fibres 
can reach the pleura via the capillary system and transfer through the visceral pleura. 
The parietal pleural has pores of relatively large diameter (about 150-200 nm), and the 
pleural fluid drainage goes through stomatas where particles are found to be 
concentrated.  
Translocation of CNTs to the pleura can be assumed, as asbestos fibres are not the 
only particles to be translocated to this site. Migration was observed after inhalation 
of refractory ceramic fibres and NMVF10a fibreglass in hamsters and rats, and 
anthracotic areas (“black spots”) containing particulate matter are present in human 
pleura [81,84-87]. One important point for the study of CNT toxicity is therefore to 
determine their ability to be distributed in the body and to reach the pleura. It is likely 
that the CNT aggregation state will modulate the rate of translocation. Recent 
experiments comparing inhalation and tracheal or pharyngeal deposition of CNTs 
concluded that the different effects were likely related to a difference in the dispersion 
and aggregation state of the CNTs [58,59]. It can also be assumed that the CNT pre-
treatments used for particle dispersion will also influence the biodistribution of these 
particles. Moreover, it must be kept in mind that CNT exposure takes place via routes 
other than inhalation, which ought to be investigated. 
3.3 Biological and genomic effects of asbestos fibres on 
mesothelial cells 
3.3.1. Inflammation and mesothelial cell activation 
Many authors have described the inflammatory processes occurring in the lung and in 
the pleura, and shown that fibres can interact with mesothelial cells in culture 
conditions. Fibre deposition in the lung is followed by the recruitment of 
inflammatory cells, which produce several factors: ROS (reactive oxygen species), 
RNS (reactive nitrogen species), clastogenic factors and cytokines that may stimulate 
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and/or damage neighbouring mesothelial cells. Fibres also may produce ROS. 
Moreover, mesothelial cells respond by fibre internalisation according to a phagocytic 
process associated with oxidative reactions [34,88-93]. 
In this situation, mesothelial cells adapt to the oxidative environment by oxidative 
stress, increasing oxidant defences and decreasing natural ROS and RNS production. 
At the same time, several regulatory pathways are activated: signalling pathways 
(MAPKs) associated with cell proliferation and apoptosis, and DNA repair and 
control of cell cycle progression in response to DNA damage [94,95]. These different 
reactions are the consequence of 2 types of interactions: between cells (inflammatory 
cells/mesothelial cells) and between cells and fibres. As neoplastic transformation is 
linked to genetic damage and requires proliferation steps, comparison between the 
genotoxic effects of asbestos and CNTs might provide clues making it possible to 
develop hypotheses about the potential effects of CNTs. 
3.3.2 Genotoxicity 
Many investigations have focused on DNA damage provoked by asbestos fibres in 
mesothelial cells. Several studies have demonstrated different types of DNA damage 
(DNA breakage, base oxidation), and perturbation of the mitotic process [94,95], 
showing that base oxidation and DNA breakage (single strand and double strand 
breaks) were detected in asbestos-treated mesothelial cells [95-100]. These may be 
due to ROS / RNS production and to the mesothelial cells’ ability to phagocytise 
asbestos fibres. Fibre uptake does not abolish the mitotic process as some fibres are 
found in dividing mesothelial cells. Moreover, extensive chromosome damage was 
described. A list of chromosome abnormalities has been reported by different authors. 
Asbestos fibres produce structural chromosome alterations; significant enhancement 
of aneuploid cells, abnormal anaphases and telophases [101-105]. Induction of 
 - 15 - 
micronuclei by all types of asbestos in primary cultures of human mesothelial cells 
has been reported by Poser et al. [106]. Other studies have shown genomic alterations 
in asbestos-treated human mesothelial cells. Loss of heterozygosity was detected as 
asbestos-induced mutations in a human mesothelioma cell line [107]. Using 3D 
reconstruction, Cortez et al. recently reported mitotic abnormalities, centrosome 
amplification and aneuploid cell formation in lung carcinoma cells, even with long 
periods of recovery post-treatment [108]. These findings are similar to earlier reports 
concerning rat pleural mesothelial cells and using less powerful methods. 
3.3.3 Gene expression in asbestos-treated mesothelial cells 
A few studies have investigated gene expression in asbestos-treated mesothelial cells 
using microarray analysis (Table 3) [109-111]. They confirmed results obtained in 
studies focusing on given types of damages. Modulation of several biological 
processes were observed. They were associated with inflammatory, proliferation, 
DNA repair and cell adhesion pathways. Further studies comparing the cell response 
to CNTs and to the different types of asbestos fibres are likely to be informative in 
order to approach the possible effects of CNTs. 
3.3.4 Gene alterations in mesothelioma 
Epidemiological studies have shown that MM is a consequence of asbestos exposure 
in a majority of cases [18-24]. This led us to assume that genomic alterations found in 
MM could be linked to the effect of asbestos fibres. The identification of these 
changes can provide insight into the molecular mechanism of action of asbestos on 
mesothelial cells. MM cells exhibit frequent alterations in tumour suppressor genes 
found at the INK4 locus, and often the type of alteration is deletions. NF2 is another 
frequently inactivated tumour suppressor gene in MM cells. Germinal mutations in 
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NF2 are responsible for type 2 neurofibromatosis, but NF2 patients are not prone to 
develop mesothelioma. TP53 is mutated less often in MM cells. 
To investigate whether genetic alterations in mesothelioma might be relevant to the 
effect of asbestos fibres, animal models of human MM are developed. Mesotheliomas 
develop following exposure, by intraperitoneal injection, of hemizygous NF2 mice to 
asbestos fibres [112,113]. This made it possible to compare characteristics of mouse 
and human mesotheliomas. 
Histologically, very similar tumours were observed, and the genomic alterations in the 
tumour suppressor genes investigated were very close to those observed in human 
MM. These gene are involved in the control of cell cycle and junction stability. 
Regarding the function of the gene, it might be of interest to determine the 
consequences of CNT exposure on cell cycle progression and cell architecture. 
4. Asbestos fibre characteristics related to disease 
 
If one looks at fibre parameters, several features appear to be shared by CNTs and 
asbestos fibres. To compare CNTs and asbestos fibres in relation to toxic potential, we 
should focus on the asbestos characteristics modulating asbestos toxicity. Shape, size, 
chemistry and surface reactivity are all related to cell and tissue responses to asbestos 
fibres. 
4.1 Shape 
CNTs have a thin and elongated shape compatible with a fibre, according to the WHO 
fibre definition of a particle with parallel edges and an aspect ratio (length/diameter) 
greater than three. It seems that CNTs are prone to form aggregates, ropes and 
clumps, a feature that is not fully similar to asbestos, which forms bundles of rather 
well-organized structures. The length of CNTs may vary, reaching up to several 
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micrometers or longer [7,114]. Accordingly, “frustrated phagocytosis” was observed 
in cells engulfing long CNTs [37]. 
4.2 Size 
 The diameters of asbestos fibres fall in the nanosize range. If one refers to the 
dimensions of the UICC samples, which have been used in a number of animal and 
cell studies, the diameter of chrysotile fibres was less than about 100 nm, and 200 nm 
for crocidolite. Length depended on the sample, but generally averaged several 
micrometers. However, there was a significant range in length and a small percentage 
of fibres longer than 10 µm were generally present. 
4.3 Chemistry 
Metals are considered to be important elements to account for fibre toxicity. Iron 
content, either structural or as contaminant, may be linked to the formation of ROS 
and RNS. Depending on the method of production, CNTs may contain metals as 
contaminants; moreover, they can be functionalized to acquire specific properties. 
Data in the literature show a wide qualitative and quantitative diversity of metal 
contaminants in the chemical composition of CNT samples, emphasizing the 
importance of using well-defined samples for toxicological analyses [7].  
4.4 Surface reactivity 
Surface reactivity is an important parameter in asbestos-related effects. The 
production of ROS and RNS was mentioned above. It is interesting to note that some 
studies indicate that, in contrast to asbestos, CNTs quench ROS in an acellular system 
generating hydroxyl radicals [115]. While asbestos fibres are hydrophilic, CNTs, 
unless functionalized, are hydrophobic. As a result, CNTs are often treated with 
dispersing agents prior to exposing cells or animals to CNTs suspended in aqueous 
medium.  
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Asbestos fibres’ ability to adsorb biological molecules is another fibre parameter to 
take into consideration. Asbestos adsorbs proteins and phospholipids, which has 
consequences on cell-fibre interactions. An enhancement of biological effects can be 
observed (particle internalisation, cytotoxicity), as well as a reduction of toxicity 
[116-119]. 
Asbestos bodies are structures found in the lung of asbestos-exposed subjects. They 
consist of an asbestos fibre core surrounded by a complex coat produced by the cell 
and tissue reaction; they are made of apatite mineralization and protein aggregation 
(hemosiderin, ferritin). These structures are more likely formed on amphiboles rather 
than on chrysotile. They are not specific to asbestos, as they have been reported in 
other fibrous and non-fibrous particles. It would be of interest to know whether these 
structures could be formed on CNTs [120-122]. 
4.5 Biopersistence 
While biopersistence is not an intrinsic particle parameter, it has received attention for 
the evaluation of the carcinogenic potency of manmade vitreous fibres (MMVFs) 
[123,124]. Biopersistence in the lung is the result of a clearance mechanism and the 
behaviour of fibres in the biological medium. Clearance depends on particle uptake by 
scavenger cells; it is then modulated by the fibre size and toxicity (short particles are 
eliminated following uptake by macrophages; cytotoxic particles impair the process). 
The behaviour of the fibres is also size-dependent (fibre dimensions govern the 
mechanism and site of deposition in the lung), as well as dependent on the fibre 
structure and chemistry (these parameters modulate the stability of the particles in the 
biological medium). Some chemical elements may dissolve and reduce fibre strength, 
breaking the fibres into smaller fragments. Finally, biopersistence modulates the 
amount of fibre retained in the lung and the time it remains in the lung. To date, CNTs 
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have been considered biopersistent, but further studies are needed to determine the 
relevance of this parameter in the context of human exposure to CNTs [57]. 
5. Discussion  
CNTs are valuable industrial products with multiple applications in the field of 
nanotechnologies, yet legitimate concerns about their potential adverse effects on 
human health need to be addressed. The risk of MM, a primary pleural carcinoma 
linked to asbestos exposure, must be examined in light of the physical nature of 
CNTs, which are elongated and ultrafine, and the fact that human beings may be 
exposed to CNTs through inhalation. While not yet definitive, data are now available 
providing information on the pulmonary and cellular effects of CNTs, which may be 
compared to those of asbestos fibres. Moreover, the asbestos fibre characteristics 
involved in the toxic processes may be compared to those of CNTs to determine their 
similarities. These comparisons make it possible to develop hypotheses about 
common and different mechanisms of action. A summary of comparisons between 
CNTs and asbestos is provided in Tables 4 and 5. 
A paradigm for the health effects of HARN has emerged from toxicology studies of 
industrial fibres, including asbestos. A recent report reviewed state-of-the-art 
knowledge of the toxicity of asbestos and HARN [3]. This clearly suggest a 
community of toxicological features and concern between HARN of different origin 
and composition. The reader will find in this quoted review additional information on 
other HARN (nanowires, nanorods) and the proposal for a research strategy to 
determine the potential toxicity of HARN. 
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5.1 Shape, structure and chemistry 
Both CNTs and asbestos particles share fibrous morphology, and their dimensions are 
in the same range. CNTs are manufactured in two main forms, SWCNTs and 
MWCNTs. A SWCNT is a single-layer graphene sheet rolled up in a cylindrical 
shape, whereas a MWCNT contains several layers [125]. The structure of chrysotile 
presents similarities with MWCNT. CNT samples may have much higher length than 
asbestos fibrils and form clumps resulting in different presentation and tissue 
penetration. One role of CNT sample dispersion to modulate biological effects is 
suggested by the results reported from in vivo experiments studying inhalation and 
intratracheal deposition.  
5.2 Biodistribution 
Similarly to asbestos fibres, CNTs may be deposited and retained in the lung after 
inhalation. So far, there is no definitive data on their migration and long-term 
retention, and on their translocation to the pleura. Interaction with mesothelial cells is 
likely important to account for asbestos pathogenicity; however, distant effects after 
deposition in the lung have been reported. As already mentioned, CNTs are the 
subject of scientific interest for a large number of already mature or potential 
applications. One paradox is that biological studies with CNTs are designed to 
investigate both adverse (exposure to toxic dust) and beneficial (nanomedicine) 
effects. These different types of studies show that MWCNTs are concentrated in the 
lymph nodes after deposition in the lung, and that functionalized MWCNTs also 
accumulate in lymph nodes after subcutaneous injection [29,126]. CNT 
biodistribution has been studied following intraperitoneal or intravenous injection in 
mice. CNTs are distributed throughout the entire body and cleared via urine excretion. 
McDevitt et al. found an accumulation of labelled SWCNTs in the kidney, liver, 
 - 21 - 
spleen and, to a lesser extent, in bone [127]. There is to date no reason to exclude the 
possibility of CNT translocation to the serosa. 
In a recent paper, Hankin et al. [128] summarized the research required into the 
mechanism of translocation of nanoparticles across the respiratory epithelium, and the 
resulting possible effects in and beyond the lung. The authors provide 
recommendations to develop research on translocation and penetration of 
nanoparticles that take into consideration the parameters allowing a robust 
interpretation of the data. 
5.3 The relationship between structure and biological effects 
Based on our present knowledge, a comparison between cell responses to SWCNTs 
and MWCNTs cannot be established. This is partly due to the limited number of 
investigations carried out with both types of nanotubes in the same assays. 
Nevertheless, both types are able to induce biological responses in one or several cell 
types, and in the lung. While studying the biodistribution of MWCNTs following 
intraperitoneal injection, Guo et al. compared different results obtained with both 
SWCNTs and MWCNTs [129]. These authors suggest that toxic responses observed 
in the kidney in some studies may depend on whether CNTs are functionalized, a 
procedure that may improve the biocompatibility. 
Surface functionalization, purity and treatment of CNTs appear to modulate the 
biological response, as found in different studies [115,130,131]. The surface 
modifications of CNTs developed in the field of nanomedicine studies are of interest 
to learn about interactions between CNTs and cells or organelles. It is already known 
that surface changes influences cell responses. Viability of neuroblastoma cells was 
not affected by pure MWCNTs (99% purity). Viability and proliferation were reduced 
after acid treatment or when MWCNTs of lower purity were used (97%) [131]. Acute 
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pulmonary toxicity and genotoxicity of MWCNTs were reduced upon heating but 
restored upon grinding, in relation with surface defects[57] 
Studies carried out with asbestos have demonstrated that long and thin fibres are more 
toxic than short fibres, without excluding potential toxicity for short fibres. Limits of 
4 µm or 8 µm in length have been proposed, mainly based on in vivo experiments. 
CNTs can fulfil these length criteria, and similarly to asbestos, long CNTs were more 
active than short CNTs [37]. More data on size-dependent biological effects of CNTs 
will be of great interest. 
Surface reactivity of asbestos fibres has been largely advanced as a key parameter 
accounting for their toxicity in terms of ROS production and sorptive abilities. ROS 
production is associated with cytotoxicity, cell activation, and chromosome and DNA 
damage. Conflicting data are found with CNTs, as both production and scavenging of 
ROS were described. CNTs are a large family regarding their method of generation, 
treatment and functionalization. Hence the surface reactivity of CNTs towards 
biological systems will be largely dependent on the type of nanotubes. This may be 
maximized by treatments to disperse CNTs prior to use for biological studies. 
Different CNTs samples may have more heterogeneous surface activities than 
asbestos.  
5.4 Biological effects 
Available data in the literature concerning the effects of CNTs on mesothelial cells 
remain limited. Several effects of asbestos fibres, especially genetic damage, are 
related to fibre internalisation. While asbestos fibres are clearly internalized by 
mesothelial cells, there is no definitive data on CNT uptake by these cells. The 
physico-chemical properties of CNTs are likely to take into consideration in the 
occurrence of this physiological process. 
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Animals and cell systems exposed to CNTs appear to develop several responses 
similar to those observed with asbestos. There is some evidence that CNTs produce 
inflammation and mesothelioma when inoculated in the peritoneal cavity of mice. 
This result is consistent with inflammatory potency after inhalation or intratracheal 
instillation. Several CNT-exposed mammalian cells respond in culture conditions by 
inflammatory reactions and oxidative stress. Genotoxic potency has been reported in 
different cell types, including mesothelial cells, as well as in studies conducted in 
vivo. Hence CNTs used in experimental systems fulfil several criteria to elicit tissue 
injury, including the mesothelium. 
6 Conclusions  
The link between asbestos effects and mesothelioma has been attributed to several 
mechanisms. This link has been investigated using different animal models and cell 
types, and substantial similarities exist in the responses of the different cell types. 
Several fibre properties have been linked to adverse effects. Shape, dimension and 
surface reactivity are all important parameters. Reactive species may produce DNA 
lesions (base oxidation, breaks); their origin is related both to fibre surface reactivity 
and phagocytosis. Inflammation contributes to the production of ROS/RNS. 
Chromosome damage appears to be of major importance to account for the significant 
effects of asbestos. Gene deletions and recombinations might result from these effects. 
Integrity of some cell processes may be critical in the response to asbestos: dynamics 
of the cell membrane (fibre uptake, cell division) and control of cell division (check 
points, chromosome segregation processes, repair of DNA breakage, cytokinesis). In 
view of findings of a much less hazard of short than some long/non-biopersistent 
HARN, more information is needed on the CNTs’ characteristics and conditions to 
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which we may be exposed. Based on available data in the literature and knowledge of 
the mechanisms of action of asbestos fibres, it appears that CNTs may elicit responses 
that are similar to those caused by asbestos fibres.  
In this review, for the sake of brevity, CNTs have been considered as a single entity. 
However, there is a large degree of heterogeneity within the CNT family. The legacy 
of our knowledge on the mechanism of action of asbestos prompts us to recognize 
some similarities between these two types of particles. Nevertheless, in view of the 
diverse uses of CNTs, toxicological studies should be carried out in the context of the 
respective applications, taking into consideration the possible interactions between the 
target tissue and the nanotubes, and their possible biodistribution. An evaluation of 
the conditions and type of exposure to CNTs thus appears mandatory to focus clearly 
on the safety and health issues. Exposure by inhalation for aerosolized CNTs must 
take into consideration both lung and pleural diseases. 
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Table 1 - Summary of recent in vivo experiments carried out with CNTs  
Type of CNT System Summary results Reference 
SWCNTs  
(Carbon nanotech Inc. Tx). 
Ø: 0.8-1.2 nm 
L: 0.1-1µm 
Pharyngeal deposition in C57Bl/6 mice lung 
(40 µg/mouse). Observation 4 hours post 
exposure.  
Gene expression in lung and blood: Upregulation of 
genes involved in inflammation, oxidative stress, 
coagulation, tissue remodeling. Increased percentage 
of polymorphonuclear leucocytes (PMN) in blood and 
bronchoalveolar lavage (BAL).  
[30] 
Inhalation (4 days) in mice – 5 mg/m³ 
Short and mean term responses (1, 7, 28 days) 
Lung analysis: Inflammation - Granulomas - Fibrosis - 
Mutation of K-ras 
SWCNTs.  
240 nm (mode, 
aerodynamic diameter; in 
number) 
4.2 µm (mode, 
aerodynamic diameter; in 
mass) 
Laryngeal deposition (10µg/mouse). 
Short and mean term responses (1, 7, 28 days) 
Lung analysis: Inflammation - Granulomas - Fibrosis - 
No mutation of K-ras. Lower effects compared to 
inhalation. 
[58] 
MWCNTs. 
Ø: 40-60 nm 
L: 0.5-500 µm 
Intratracheal deposition in rats.  
One to 7 mg/kg. Short / mean term responses 
(1 to 90 days) 
Inflammation; dose-dependent thickening of the 
alveolar lining 
Particles still present after 3 months 
[56] 
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MWCNTs grinded, 
unheated, heated to 600°C, 
2400°C; 2400°C then 
grinded.  
Ø: 20-50 nm 
L: 0.7±0.07 µm 
Intratracheal deposition in rats, 2mg/rat. 
Short-term response (3 days); mean-term (60 
days) 
Inflammation (3 days). Granulomas (60 days). 
Effects of heated CNTs lower than unheated. 
Grinding restored the effects. 
[57] 
MWCNTs. 
 Ø: 40-60 nm 
L: 0.5-500 µm 
Intratracheal deposition in rats. One to 7 
mg/kg. Short / mean term responses (1 to 90 
days) 
Inflammation; dose-dependent thickening of the 
alveolar lining 
Particles still present after 3 months 
[56] 
MWCNTs 
(Mitsui & Co., LDT) 
Ø: ≈ 80 nm 
L: 10-20 µm 
Pharyngeal deposition in C57Bl/6 mice lung 
(40 µg/mouse). Observation 4 hours post 
exposure. 
Gene expression in lung and blood: Upregulation of 
genes involved in inflammation, oxidative stress, 
coagulation, tissue remodeling. Increased percentage 
of polymorphonuclear leucocytes (PMN) in blood and 
bronchoalveolar lavage (BAL). 
[30] 
Inhalation (≈ 32 mg/m
3
) in mice for 5, 10, 15 
days; deposition ≈ 0.07, 0.14; 0.24 µg/mouse. 
Short-term response (8, 16, 24 days) 
Small aggregates entering the alveolar wall  
Cell proliferation and thickening of alveolar walls 
MWCNTs 
Shenzhen nanotech 
Ø: 500 nm;  
L: 10 µm 
 
Tracheal deposition: 50 µg/mouse 
 
Eight and 16 days: clumps deposited on lining wall of 
bronchi, no inflammation - 24 days: inflammation.  
Clumps in the alveoli destruction of alveolar structure 
[59] 
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Table 2 - Summary of recent in vitro experiments carried out with CNTs 
Type of CNT System Summary results Reference 
SWCNTs (HiPco), (CNI Inc.). 
Ø: 0.4–1.2 nm 
L: 1-3 µm 
Lung hamster fibroblasts (V79) Cytotoxicity (time and dose dependent) 
DNA breakage (comet assay)  
No significant enhancement of micronuclei 
[62] 
SWCNTs (50% SWCNT, about 
40% other nanotubes).  
Ø: 1.1 nm, L: 0.5-100 µm 
BEAS 2B human bronchial epithelial cells Dose-dependent decrease in cell viability. Dose-
dependent DNA damage. No formation of 
micronuclei 
[63] 
SWCNTs (NIST) 
Ø: 1.4 nm, L: 2-5 µm 
Normal human mesothelial cells and human 
mesothelioma cell line 
 
Cell death. DNA lesions 
Stress response activation 
[44] 
SWCNTs. Folate conjugated.  
Ø: 1-3 nm, L: 100 - 200 nm 
HepG2 cells (express folate receptor) No toxicity if <50µg/ml. Dose-dependent 
apoptosis. Kinetics of SWCNT internalisation: 
Mb → cytoplasm → extracellular 
[64] 
SWCNTs (HiPco) Human lung epithelial cells A549 and 
immortalised NHBE 
Decreased inflammatory response in TNF alpha-
stimulated cells 
[65] 
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SWCNTs Mitsui & Co., Ltd 
Size unspecified 
Human aortic endothelial cells Internalisation: CNTs identified in the 
cytoplasm. Cytotoxicity. IL-8 release. Actin 
filament and E cadherin disruption. Reduced 
tubule formation. 
[66] 
SWCNTs Mouse embryo fibroblasts Low cytotoxicity. DNA damage (comet assay) 
Oxidative stress 
[67] 
MWCNTs. 
Ø: 67 nm 
 
Mouse macrophages (J774.1).  No MAPKs activation; no apoptosis. 
Interaction with membrane receptors (MARCO) 
and plasma membrane destruction 
[54] 
MWCNTs.  
Ø: 11.3 nm 
L: 0.7 µm 
Human epithelial cells (MCF-7) 
 
Chromosomal aberrations (micronuclei) 
showing chromosome breakage and loss of 
whole chromosomes 
[61] 
MWCNTs (C100, Arkema).  
Ø: 12 nm, 
L: 0.1-13 µm  
Human epithelial (A549) and Large T SV40 
transformed mesothelial (Met-5A) cells 
Decrease in cell viability (mitochondrial 
alteration) without apoptosis. No oxidative 
stress. No MWCNT internalisation 
[46] 
MWCNTs grinded, unheated, 
heated to 600°C, 2400°C; 2400°C 
then grinded.  
Ø: 20-50 nm; L: 0.7±0.07 µm 
Rat lung epithelial cells. Chromosomal aberrations (micronuclei) 
Lower effects with 2400°C sample in 
comparison to 600°C and unheated 
[57] 
MWCNTs. 
 Ø: 100-200 nm, L: a few µm 
Human epithelial cells (A549) 
 
DNA breakage (comets). 
No oxidative DNA lesions 
[68] 
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MWCNTs 
(Tsinghua & Nananfeng, Cine) 
Mouse embryonic cells (ES) P53 activation. Induction of DNA repair.  
Mutations (adenine phosphoribosyl transferase) 
[69] 
MWCNTs Mitsui & Co., Ltd 
Size unspecified 
Human aortic endothelial cells 
Cytotoxicity. IL-8 release. Actin filament and 
E cadherin disruption. Reduced tubule 
formation. 
[66] 
MWCNTs Human pneumocytes A549 Decrease in cell viability  
Internalisation 
[70] 
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Table 3 – Summary of in vitro experiments related to gene expression in crocidolite-treated 
mesothelial cells 
 
System Summary results Reference 
Human mesothelial cells (LP9/TERT-1) 
exposed to low and high concentrations (15 and 
75 µm²/cm² per dish) for 8 or 24h 
Oligonucleotide microarray analysis 
ATF3-dependent modulation of inflammatory 
cytokines and growth factor production 
[109] 
Human SV40-immortalized pleural mesothelial 
(MeT-5A) cells exposed to 1 µg/cm
2
 dish for 1-
48h 
Oligonucleotide microarray analysis 
1h: upregulation of nucleosome assembly, 
translational initiation, transcription, I-kappaB 
kinase/NF-kappaB cascade, survival 
48h: downregulation of cytoskeletal anchoring, 
transcription, survival 
[110] 
Normal rat pleural mesothelial cells exposed to 
5 µg/cm
2
 dish for 24h 
Oligonucleotide microarray analysis 
Induction of fra-1-linked cd44 and c-met expression  
[111] 
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Table 4: Comparison between physical and chemical parameters of asbestos and CNTs 
 
Parameter Comparison 
Shape Both are elongated particles; fibre shaped. 
Dimensions Asbestos fibre diameter: range of 100 nm. Chrysotile fibrils: ≈ 50 nm of diameter. Same order as MWCNTs.  
Structure 
Chrysotile: multi-layered rolled sheets of brucite (MgOH
2
) and silicon oxide (SiO
2
). Important aggregation 
with CNTs, which may form more entangled bundles, ropes, than asbestos. 
Chemistry Different chemistry. Possibility of metal impurities in both asbestos and CNTs. 
Surface reactivity Both show sorptive properties to biological molecules. ROS production: no definitive answer for CNTs. 
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Table 5: Comparison between biological effects of asbestos and CNTs 
 
Cell / tissue response Comparison 
Particle uptake 
Demonstrated with both types. Conflicting results with CNTs. Exocytosis found with 
CNTs, so far not investigated with asbestos. 
Cytotoxicity Both cytotoxic. 
DNA damage, mutation, gene interaction Found with both asbestos and CNTs. 
Transfection Gene transfer is with asbestos. CNT gene knockdown. 
Biodistribution Both types are cleared via the lymphatic system and found in different organs 
Inflammation, granulomas, fibrosis 
Found with both asbestos and CNTs. Both types show dependence of biological effects 
with fibre dimensions: bioactivity of long fibres. 
Cancer  MM found with both asbestos and CNTs by peritoneal exposure. 
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